Status | Study |
Active, not recruiting |
Study Name: Low Rectal Cancer Study (MERCURY II) Condition: Adenocarcinoma Adenocarcinoma, Mucinous Carcinoma Date: 2013-11-21 |
Active, not recruiting |
Study Name: Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial Condition: Adenocarcinoma Rectal Diseases Colorectal Neoplasms Date: 2013-11-21 |
Completed |
Study Name: Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms Condition: Neoplasms, Cystic, Mucinous, and Serous Date: 2013-09-30 Interventions: Drug: Ethanol EUS-guided lavag |
Active, not recruiting |
Study Name: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2012-07-15 Interventions: Biological: Dalantercept Given |
Terminated |
Study Name: Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm Condition: Mucinous Cystic Tumor With Moderate Dysplasia Mucinous Cystadenoma of Pancreas Date: 2012-02-01 Interventions: Drug: Ethanol and Paclitaxel Injection Endoscopic ultrasound will be used to locate and assess the pancr |
Recruiting |
Study Name: Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy Condition: Adenoid Cystic Carcinoma Squamous Cell Carcinoma Sinonasal Date: 2011-10-21 Interventions: Radiation: Proton radiation therapy |
Active, not recruiting |
Study Name: Results of CRS and Debulking in PMP Patients Condition: Pseudomyxoma Peritonei Date: 2011-08-31 |
Completed |
Study Name: Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Clear Cell Adenocarcinoma Date: 2010-10-20 Interventions: Drug: Nintedanib Given PO Other Names: |
Completed |
Study Name: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2010-05-27 Interventions: Drug: Cediranib Maleate Given |
Withdrawn |
Study Name: Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms Condition: Neoplasms, Cystic, Mucinous, and Serous Pancreatic Neoplasms Date: 2010-01-26 Interventions: Procedure: EUS and/or ERCP with ethanol injections of pancreatic cyst Lavage of cyst with 80% ethanol |